Vector-borne diseases (VBDs) represent a significant public health concern in India, contributing to substantial morbidity and mortality. This review aims to provide a comprehensive overview of the prevalence and impact of VBDs in India for healthcare professionals.
India's diverse ecology contributes to the prevalence of various VBDs, including Malaria, Dengue, Chikungunya, and Japanese Encephalitis. Malaria, predominantly caused by Plasmodium falciparum and P. vivax, remains a significant health issue, with an estimated 5.6 million cases reported in 2019. Dengue, another critical VBD, has seen an exponential rise, with an estimated 100,000 cases annually. Chikungunya and Japanese Encephalitis also persist as endemic diseases in several regions.
VBDs impose a substantial health burden, causing significant morbidity and mortality. They also strain the healthcare system and hinder socioeconomic development. The direct impact includes the cost of healthcare and loss of productivity due to illness. The indirect impact involves the cost of vector control measures and the socio-economic burden on families and communities.
Several challenges impede the control of VBDs, including inadequate surveillance, vector resistance to insecticides, and climate change. Addressing these challenges requires a multi-pronged approach, including strengthening surveillance systems, promoting research in vector control, and enhancing community participation in disease prevention.
Vector-borne diseases remain a prominent public health issue in India, causing significant morbidity and mortality. A comprehensive understanding of these diseases, their impact, and the challenges in controlling them is crucial for healthcare professionals. This knowledge will enable the development and implementation of effective strategies for the prevention and control of VBDs in India.
1.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
Low Income, Education Tied to Depression in Older Adults
5.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
1.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
2.
Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies
3.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
4.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
5.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Navigating the Complexities of Ph Negative ALL - Part XV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation